| ID: 127275848 | NANOG hESC enhancer GRCh37_chr2:222441193-222441705 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (221576473..221576985) | | |
| ID: 127275847 | H3K4me1 hESC enhancer GRCh37_chr2:222391836-222392336 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (221527116..221527616) | | |
| ID: 127275846 | OCT4-NANOG hESC enhancer GRCh37_chr2:222333354-222333959 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (221468634..221469239) | | |
| ID: 127275845 | OCT4-NANOG hESC enhancer GRCh37_chr2:222332747-222333353 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (221468027..221468633) | | |
| ID: 127275844 | H3K27ac hESC enhancer GRCh37_chr2:222236463-222236962 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (221371743..221372242) | | |
| ID: 127275843 | NANOG hESC enhancer GRCh37_chr2:222109712-222110223 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (221244992..221245503) | | |
| ID: 127275842 | H3K4me1 hESC enhancer GRCh37_chr2:222034243-222034742 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (221169523..221170022) | | |
| ID: 126806527 | BRD4-independent group 4 enhancer GRCh37_chr2:222289669-222290868 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (221424949..221426148) | | |
| ID: 121725116 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr2:222381886-222383085 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (221517166..221518365) | | |
| ID: 106479054 | transmembrane protein 256 pseudogene 2 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (221532668..221533008) | | |
| ID: 105373897 | uncharacterized LOC105373897 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (221587411..221610420, complement) | | |
| ID: 402120 | ribosomal protein L23 pseudogene 5 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (221592433..221592931) | RPL23_3_328 | |
| ID: 2043 | EPH receptor A4 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (221418027..221574202, complement) | EK8, HEK8, SEK, TYRO1 | 602188 |